Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Application of a combination of lactated Ringer's solution and ulinastatin for early resuscitation in sepsis

Yuyuan Min, Yinbin He, Lei Tuo, Meizi Fan, Yaning Xie

Department of Anesthesia and Perinatal Medical Center, Xi'an People's Hospital, Xi'an City, Shaanxi Province 710100, China;

For correspondence:- Yaning Xie Email: XieYaning618@hotmail.com

Accepted: 27 November 2023 Published: 31 December 2023

Citation: Min Y, He Y, Tuo L, Fan M, Xie Y. Application of a combination of lactated Ringer's solution and ulinastatin for early resuscitation in sepsis. Trop J Pharm Res 2023; 22(12):2525-2530 doi: 10.4314/tjpr.v22i12.15

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of early resuscitation using a combination of lactated Ringer's solution and ulinastatin on the survival rate of patients with sepsis.

Methods: 82 patients with septic shock admitted to Xi'an People's Hospital, China from June 2017 to December 2020 were enrolled and randomly divided into control and study groups (n = 41 each). Patients in control group were given conventional fluid resuscitation and anti-infective therapy, while patients in study group were additionally given ulinastatin. Acute physiology and chronic health evaluation (APACHE II) score, sequential organ failure assessment (SOFA) score, and tissue perfusion were determined. Also, mechanical ventilation time, intensive care unit (ICU) stay time, and 28-day mortality rates were recorded.

Results: Both groups presented no significant difference in clinical characteristics before treatment. After treatment, APACHE II score, SOFA score, and lactic acid level of the study group significantly decreased (p < 0.05), and the patients’ condition improved. Moreover, inflammation-related indices, viz, procalcitonin (PCT), white blood cells (WBC), and C reactive protein (CRP) were significantly reduced in the study group (p < 0.05). Renal function-related indices which include creatinine, and blood urea nitrogen (BUN) significantly decreased in study group (p < 0.05). Mechanical ventilation time, and ICU stay time were significantly shortened (p < 0.0001), while short-term survival rate significantly improved (p < 0.05).

Conclusion: Lactated Ringer's solution in combination with ulinastatin expedites tissue perfusion and recovery, suppresses inflammation, enhances renal function, and significantly enhances the survival rate of septic patients. These findings provide valuable information for exploring new therapeutic approaches to sepsis.

Keywords: Lactated ringer's solution, Ulinastatin, Sepsis